Macular Degeneration Clinical Trials

305 clinical trials for Macular Degeneration across international registries, including 32 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy — RECRUITING
• A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) — RECRUITING · PHASE2
• A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) — RECRUITING · PHASE2
• Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration — RECRUITING · PHASE4
• A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — RECRUITING · PHASE2
• Stem Cell Ophthalmology Treatment Study II — RECRUITING · NA
• Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss — RECRUITING · NA
• Factors in Learning And Plasticity: Macular Degeneration — RECRUITING · NA
• A RANDOMIZED, DOUBLE MASKED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGE FINDING STUDY TO ASSESS THE EFFICACY AND SAFETY OF FWY003 IN PARTICIPANTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. — RECRUITING
• Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium — RECRUITING · PHASE1
• Learning Study: Improving Vision in Adults With Macular Degeneration — RECRUITING · NA
• LADIGAGA - Long–term Analysis of DImethyl fumarate, to slow the Growth of Areas of Geographic Atrophy — RECRUITING · PHASE2
• Natural History Study of Inherited Retinal Diseases — RECRUITING
• A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema — RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, DOUBLE-MASKED, ACTIVE-CONTROLLED TRIAL OF A SINGLE LNTRAVITREAL INJECTION OF 4D-150 IN ADULTS WITH MACULAR NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION (4FRONT-1) — RECRUITING · PHASE3
• A PHASE 2 MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM CONTROLLED, REFERENCE-ARM STUDY TO EVALUATE EFFICACY AND SAFETY OF ONL1204 IN PATIENTS WITH GEOGRAPHIC ATROPHY (GA) ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION (AMD) — RECRUITING · PHASE2
• Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION — RECRUITING · PHASE1
• Implementation of the Intravitreal Injection Administered by Nurses — RECRUITING
• A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT — RECRUITING
• Analysis of Biomarkers From Patients With Chorioretinal Diseases — RECRUITING
• NYSCF Scientific Discovery Biobank — RECRUITING
• PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-MASKED, 2-ARM, SHAM CONTROLLED STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF ANX007 ADMINISTERED BY INTRAVITREAL INJECTION IN PATIENTS WITH GEOGRAPHIC ATROPHY (GA) SECONDARY TO AGE-RELATED MACULAR DEGENERATION (AMD) — RECRUITING · PHASE3
• A PHASE 1/2, FIRST-IN-HUMAN, MULTI-ARM, DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF AN ADENO-ASSOCIATED VIRUS VECTOR VV-14295 ADMINISTERED SUPRACHOROIDALLY WITH THE EVERADS INJECTOR IN ADULTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION (THE VISION STUDY) — RECRUITING · PHASE1
• Quest to Analyze One Thousand Humans Meditating — RECRUITING
• A MULTICENTER, RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF SUBCUTANEOUSLY ADMINISTERED POZELIMAB IN COMBINATION WITH CEMDISIRAN OR CEMDISIRAN ALONE IN PARTICIPANTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION — RECRUITING · PHASE3
• Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. — RECRUITING · PHASE1
• Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography — RECRUITING
• Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration — RECRUITING · PHASE1
• A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE RELATED MACULAR DEGENERATION — RECRUITING
• A PHASE III, MULTI-CENTER, RANDOMIZED, DOUBLE-MASKED, SHAM CONTROLLED STUDY TO COMPARE THE EFFICACY AND SAFETY OF INTRAVITREAL APL-2 THERAPY WITH SHAM INJECTIONS IN PATIENTS WITH GEOGRAPHIC ATROPHY (GA) SECONDARY TO AGE-RELATED MACULAR DEGENERATION (AMD) — RECRUITING · PHASE3
• A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION — RECRUITING · PHASE3
• THE SHIFT-2 STUDY: USE OF INTRAVITREAL AFLIBERCEPT IN WET AGE RELATED MACULAR DEGENERATION (AMD) PATIENTS WITH AN INCOMPLETE RESPONSE TO MONTHLY RANIBIZUMAB INJECTIONS — RECRUITING · PHASE2
• Macular structure and function after intravitreal injection of bevacizumab for wet macular degeneration a interventional study. — COMPLETED · PHASE2
• Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration — ACTIVE_NOT_RECRUITING · PHASE1
• Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss — NOT_YET_RECRUITING · NA
• Study of New Mutations in Cone Disorders — TERMINATED
• Ocular Imaging Study Using Advanced OCT — TERMINATED
• A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD) — COMPLETED · PHASE2
• Artificial Intelligence-assisted Diagnosis in Ophthalmology — NOT_YET_RECRUITING
• Factors in Learning And Plasticity: Healthy Vision — ACTIVE_NOT_RECRUITING · NA
• FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD — TERMINATED · PHASE1
• Ranibizumab and Reduced Fluence PDT for AMD — COMPLETED · PHASE2
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — ACTIVE_NOT_RECRUITING · PHASE2
• Scotoma Perimetry Oculomotor Training — COMPLETED · NA
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — COMPLETED · PHASE3
• Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study — ACTIVE_NOT_RECRUITING
• A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy — COMPLETED · PHASE2
• GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) — COMPLETED · PHASE2
• Advancing Understanding of Transportation Options — COMPLETED · NA
• Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) — WITHDRAWN · PHASE2

Refine this search